Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease

Journal of Physiology

Volumn 594, Issue 14, 2016, Pages 3853-3875

  Habecker, Beth A ^a   Anderson, Mark E ^b   Birren, Susan J ^c   Fukuda, Keiichi ^d   Herring, Neil ^e   Hoover, Donald B ^f   Kanazawa, Hideaki ^d   Paterson, David J ^e   Ripplinger, Crystal M ^g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRANDEIS UNIVERSITY   (United States)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f East Tennessee State University   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; NERVE GROWTH FACTOR;

ADAPTATION; ARTICLE; CARDIAC MUSCLE CELL; CELL KINETICS; CELL SURVIVAL; HEART DISEASE; HEART NERVE; HUMAN; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PARASYMPATHETIC NERVE; PARASYMPATHETIC TONE; PRIORITY JOURNAL; SENSORY NERVE; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; SYMPATHETIC TONE; SYNAPTIC TRANSMISSION;

EID: 84978904003     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271840     Document Type: Article

References (243)

1. Ahuja P, Perriard E, Pedrazzini T, Satoh S, Perriard JC & Ehler E (2007). Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp Cell Res 313, 1270–1283.
2. Ajijola OA, Vaseghi M, Zhou W, Yamakawa K, Benharash P, Hadaya J, Lux RL, Mahajan A & Shivkumar K (2013a). Functional differences between junctional and extrajunctional adrenergic receptor activation in mammalian ventricle. Am J Physiol Heart Circ Physiol 304, H579–H588.
3. Ajijola OA, Yagishita D, Patel KJ, Vaseghi M, Zhou W, Yamakawa K, So E, Lux RL, Mahajan A & Shivkumar K (2013b). Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. Am J Physiol Heart Circ Physiol 305, H1031–H1040.
4. Ambrosi CM, Klimas A, Yu J & Entcheva E (2014). Cardiac applications of optogenetics. Prog Biophys Mol Biol 115, 294–304.
5. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA & Liu DW (1991). Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res 69, 1427–1449.
6. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, Yui Y & Sasayama S (2000). Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 32, 1821–1830.
7. Ardell JL (2001). Neurohumoral control of cardiac function. In Basic and Clinical Neurocardiology, 4th edn, ed. Armour JA & Ardell JL, pp. 45–59. Academic Press, San Diego.
8. Ardell JL, Rajendran PS, Nier HA, KenKnight BH & Armour JA (2015). Central-peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac function. Am J Physiol Heart Circ Physiol 309, H1740–H1752.
9. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marban E, O'Donnell CJ, Hirschhorn JN, Kaab S, Spooner PM, Meitinger T & Chakravarti A (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38, 644–651.
10. Armour JA (2008). Potential clinical relevance of the ‘little brain’ on the mammalian heart. Exp Physiol 93, 165–176.
11. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS & Olson EN (2009). The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci USA 106, 2342–2347.
12. Bai J, Ren C, Hao W, Wang R & Cao JM (2008). Chemical sympathetic denervation, suppression of myocardial transient outward potassium current, and ventricular fibrillation in the rat. Can J Physiol Pharmacol 86, 700–709.
13. Barber MJ, Mueller TM, Henry DP, Felten SY & Zipes DP (1983). Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67, 787–796.
14. Bers DM (2002). Cardiac excitation–contraction coupling. Nature 415, 198–205.
15. Bers DM (2008). Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70, 23–49.
16. Berthoud HR & Neuhuber WL (2000). Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85, 1–17.
17. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ & Bax JJ (2010). Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55, 2769–2777.
18. Boyden ES, Zhang F, Bamberg E, Nagel G & Deisseroth K (2005). Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8, 1263–1268.
19. Brack KE, Coote JH & Ng GA (2004). Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart. Exp Physiol 89, 128–139.
20. Brack KE, Coote JH & Ng GA (2011). Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res 91, 437–446.
21. Brack KE, Patel VH, Mantravardi R, Coote JH & Ng GA (2009). Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol 587, 3045–3054.
22. Brain SD & Grant AD (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84, 903–934.
23. + channels in adrenalectomized and catecholamine-depleted reserpine-treated rats. J Mol Cell Cardiol 35, 153–163.
24. + currents in adult mouse ventricles. J Physiol 559, 103–120.
25. Bryant DM, O'Meara CC, Ho NN, Gannon J, Cai L & Lee RT (2015). A systematic analysis of neonatal mouse heart regeneration after apical resection. J Mol Cell Cardiol 79, 315–318.
26. Burnstock G (2009). Autonomic neurotransmission: 60 years since Sir Henry Dale. Annu Rev Pharmacol Toxicol 49, 1–30.
27. Calupca MA, Locknar SA, Zhang L, Harrison TA, Hoover DB & Parsons RL (2001). Distribution of cocaine- and amphetamine-regulated transcript peptide in the guinea pig intrinsic cardiac nervous system and colocalization with neuropeptides or transmitter synthetic enzymes. J Comp Neurol 439, 73–86.
28. Calupca MA, Vizzard MA & Parsons RL (2000). Origin of pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive fibers innervating guinea pig parasympathetic cardiac ganglia. J Comp Neurol 423, 26–39.
29. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC & Chen PS (2000a). Nerve sprouting and sudden cardiac death. Circ Res 86, 816–821.
30. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS & Chen LS (2000b). Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101, 1960–1969.
31. Cauley E, Wang X, Dyavanapalli J, Sun K, Garrott K, Kuzmiak-Glancy S, Kay MW & Mendelowitz D (2015). Neurotransmission to parasympathetic cardiac vagal neurons in the brain stem is altered with left ventricular hypertrophy-induced heart failure. Am J Physiol Heart Circ Physiol 309, H1281–H1287.
32. Chai W, Mehrotra S, Jan Danser AH & Schoemaker RG (2006). The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Eur J Pharmacol 531, 246–253.
33. Chang BH, Mukherji S & Soderling TR (1998). Characterization of a calmodulin kinase II inhibitor protein in brain. Proc Natl Acad Sci USA 95, 10890–10895.
34. 2+/calmodulin-dependent kinase II holoenzyme. Cell 146, 732–745.
35. Chun LL & Patterson PH (1977). Role of nerve growth factor in the development of rat sympathetic neurons in vitro. I. Survival, growth, and differentiation of catecholamine production. J Cell Biol 75, 694–704.
36. Coote JH (2013). Myths and realities of the cardiac vagus. J Physiol 591, 4073–4085.
37. Corr PB & Gillis RA (1974). Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion. Circulation 49, 86–97.
38. Cuculi F, Herring N, De Caterina AR, Banning AP, Prendergast BD, Forfar JC, Choudhury RP, Channon KM & Kharbanda RK (2013). Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction. Heart 99, 1198–1203.
39. Curran J, Tang L, Roof SR, Velmurugan S, Millard A, Shonts S, Wang H, Santiago D, Ahmad U, Perryman M, Bers DM, Mohler PJ, Ziolo MT & Shannon TR (2014). Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation. PLoS One 9, e87495.
40. Cutler MJ, Jeyaraj D & Rosenbaum DS (2011). Cardiac electrical remodeling in health and disease. Trends Pharmacol Sci 32, 174–180.
41. Dae MW, O'Connell JW, Botvinick EH & Chin MC (1995). Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 30, 270–280.
42. Dawson TA, Li D, Woodward T, Barber Z, Wang L & Paterson DJ (2008). Cardiac cholinergic NO-cGMP signaling following acute myocardial infarction and nNOS gene transfer. Am J Physiol Heart Circ Physiol 295, H990–H998.
43. De Ferrari GM, Salvati P, Grossoni M, Ukmar G, Vaga L, Patrono C & Schwartz PJ (1993). Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. J Am Coll Cardiol 22, 283–290.
44. De Ferrari GM, Vanoli E, Curcuruto P, Tommasini G & Schwartz PJ (1992). Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am Heart J 124, 883–890.
45. DeGeest H, Levy MN, Zieske H & Lipman RI (1965). Depression of ventricular contractility by stimulation of the vagus nerves. Circ Res 17, 222–235.
46. DeMazumder D, Kass DA, O'Rourke B & Tomaselli GF (2015). Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling. Circ Res 116, 1691–1699.
47. Deo SH, Barlow MA, Gonzalez L, Yoshishige D & Caffrey JL (2009). Repeated arterial occlusion, delta-opioid receptor (DOR) plasticity and vagal transmission within the sinoatrial node of the anesthetized dog. Exp Biol Med (Maywood) 234, 84–94.
48. Doust JA, Pietrzak E, Dobson A & Glasziou P (2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330, 625.
49. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ & Anderson ME (2008). A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462–474.
50. Erickson JR, Nichols CB, Uchinoumi H, Stein ML, Bossuyt J & Bers DM (2015). S-Nitrosylation induces both autonomous activation and inhibition of calcium/calmodulin-dependent protein kinase II δ. J Biol Chem 290, 25646–25656.
51. Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM & Bers DM (2013). Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502, 372–376.
52. Esler M, Kaye D, Lambert G, Esler D & Jennings G (1997). Adrenergic nervous system in heart failure. Am J Cardiol 80, 7L–14L.
53. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME & Canty JM Jr (2014). Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 63, 141–149.
54. 2-opioid receptors in sinoatrial node. Am J Physiol Heart Circ Physiol 284, H1693–H1701.
55. Farias M, Jackson K, Stanfill A & Caffrey JL (2001). Local opiate receptors in the sinoatrial node moderate vagal bradycardia. Auton Neurosci 87, 9–15.
56. Freeman K, Tao W, Sun H, Soonpaa MH & Rubart M (2014). In situ three-dimensional reconstruction of mouse heart sympathetic innervation by two-photon excitation fluorescence imaging. J Neurosci Methods 221, 48–61.
57. Fregoso SP & Hoover DB (2012). Development of cardiac parasympathetic neurons, glial cells, and regional cholinergic innervation of the mouse heart. Neuroscience 221, 28–36.
58. Fukuda K, Kanazawa H, Aizawa Y, Ardell JL & Shivkumar K (2015). Cardiac innervation and sudden cardiac death. Circ Res 116, 2005–2019.
59. Gardner RT & Habecker BA (2013). Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury. J Neurosci 33, 7175–7183.
60. Gardner RT, Ripplinger CM, Myles RC & Habecker BA (2016). Molecular mechanisms of sympathetic remodeling and arrhythmias. Circulation 9, e001359.
61. Gardner RT, Wang L, Lang BT, Cregg JM, Dunbar CL, Woodward WR, Silver J, Ripplinger CM & Habecker BA (2015). Targeting protein tyrosine phosphatase sigma after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias. Nat Commun 6, 6235.
62. Glebova NO & Ginty DD (2005). Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 28, 191–222.
63. Gourine A & Gourine AV (2014). Neural mechanisms of cardioprotection. Physiology (Bethesda) 29, 133–140.
64. 2+ leak and the pathophysiological response to chronic β-adrenergic stimulation. J Mol Cell Cardiol 85, 282–291.
65. Gritman K, Van Winkle DM, Lorentz CU, Pennica D & Habecker BA (2006). The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine 36, 9–16.
66. Gutierrez DA, Fernandez-Tenorio M, Ogrodnik J & Niggli E (2013). NO-dependent CaMKII activation during β-adrenergic stimulation of cardiac muscle. Cardiovasc Res 100, 392–401.
67. Habecker BA, Bilimoria P, Linick C, Gritman K, Lorentz CU, Woodward W & Birren SJ (2008). Regulation of cardiac innervation and function via the p75 neurotrophin receptor. Auton Neurosci 140, 40–48.
68. Hainsworth R (1991). Reflexes from the heart. Physiol Rev 71, 617–658.
69. Hansson M, Kjorell U & Forsgren S (2001). Ingrowth of sympathetic innervation occurs concomitantly with a decrease of ANP in the growing rat cardiac ventricles. Anat Embryol (Berl) 203, 35–44.
70. Hasan W, Jama A, Donohue T, Wernli G, Onyszchuk G, Al Hafez B, Bilgen M & Smith PG (2006). Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res 1124, 142–154.
71. −/− and gp130 KO mice. Neurosci Lett 529, 55–59.
72. He BJ, Joiner ML, Singh MV, Luczak ED, Swaminathan PD, Koval OM, Kutschke W, Allamargot C, Yang J, Guan X, Zimmerman K, Grumbach IM, Weiss RM, Spitz DR, Sigmund CD, Blankesteijn WM, Heymans S, Mohler PJ & Anderson ME (2011). Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 17, 1610–1618.
73. Heath BM, Xia J, Dong E, An RH, Brooks A, Liang C, Federoff HJ & Kass RS (1998). Overexpression of nerve growth factor in the heart alters ion channel activity and β-adrenergic signalling in an adult transgenic mouse. J Physiol 512, 779–791.
74. Heaton DA, Li D, Almond SC, Dawson TA, Wang L, Channon KM & Paterson DJ (2007). Gene transfer of neuronal nitric oxide synthase into intracardiac ganglia reverses vagal impairment in hypertensive rats. Hypertension 49, 380–388.
75. Hellweg R & Hartung HD (1990). Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26, 258–267.
76. Herring N (2015). Autonomic control of the heart: going beyond the classical neurotransmitters. Exp Physiol 100, 354–358.
77. Herring N, Cranley J, Lokale MN, Li D, Shanks J, Alston EN, Girard BM, Carter E, Parsons RL, Habecker BA & Paterson DJ (2012). The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. J Mol Cell Cardiol 52, 667–676.
78. Herring N, Golding S & Paterson DJ (2000). Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. J Mol Cell Cardiol 32, 1795–1804.
79. Herring N, Lee CW, Sunderland N, Wright K & Paterson DJ (2011). Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat. J Mol Cell Cardiol 50, 99–106.
80. Herring N, Lokale MN, Danson EJ, Heaton DA & Paterson DJ (2008). Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J Mol Cell Cardiol 44, 477–485.
81. Herring N & Paterson DJ (2001). Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol 535, 507–518.
82. f, and heart rate during adrenergic stimulation. Cardiovasc Res 52, 446–453.
83. Herring N, Zaman JA & Paterson DJ (2001b). Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 281, H2318–H2327.
84. Hildreth V, Anderson RH & Henderson DJ (2009). Autonomic innervation of the developing heart: origins and function. Clin Anat 22, 36–46.
85. Hiltunen JO, Laurikainen A, Airaksinen MS & Saarma M (2000). GDNF family receptors in the embryonic and postnatal rat heart and reduced cholinergic innervation in mice hearts lacking Ret or GFRα2. Dev Dyn 219, 28–39.
86. Hoard JL, Hoover DB, Mabe AM, Blakely RD, Feng N & Paolocci N (2008). Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75. Neuroscience 156, 129–142.
87. Hogan K & Markos F (2006). Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in vitro. Exp Physiol 91, 641–646.
88. Hoover DB, Ganote CE, Ferguson SM, Blakely RD & Parsons RL (2004). Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters. Cardiovasc Res 62, 112–121.
89. Hoover DB, Isaacs ER, Jacques F, Hoard JL, Page P & Armour JA (2009). Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience 164, 1170–1179.
90. Hoover DB, Shepherd AV, Southerland EM, Armour JA & Ardell JL (2008). Neurochemical diversity of afferent neurons that transduce sensory signals from dog ventricular myocardium. Auton Neurosci 141, 38–45.
91. Hopkins DA, Macdonald SE, Murphy DA & Armour JA (2000). Pathology of intrinsic cardiac neurons from ischemic human hearts. Anat Rec 259, 424–436.
92. Hulting J, Sollevi A, Ullman B, Franco-Cereceda A & Lundberg JM (1990). Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res 24, 102–108.
93. Hunt RA, Ciuffo GM, Saavedra JM & Tucker DC (1995). Sympathetic innervation modulates the expression of angiotensin II receptors in embryonic rat heart grafted in oculo. J Mol Cell Cardiol 27, 2445–2452.
94. Hwang DY, Carlezon WA Jr, Isacson O & Kim KS (2001). A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons. Hum Gene Ther 12, 1731–1740.
95. Iaccarino G, Tomhave ED, Lefkowitz RJ & Koch WJ (1998). Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade. Circulation 98, 1783–1789.
96. Ieda M & Fukuda K (2009). Cardiac innervation and sudden cardiac death. Curr Cardiol Rev 5, 289–295.
97. Ieda M, Fukuda K, Hisaka Y, Kimura K, Kawaguchi H, Fujita J, Shimoda K, Takeshita E, Okano H, Kurihara Y, Kurihara H, Ishida J, Fukamizu A, Federoff HJ & Ogawa S (2004). Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 113, 876–884.
98. Ieda M, Kanazawa H, Ieda Y, Kimura K, Matsumura K, Tomita Y, Yagi T, Onizuka T, Shimoji K, Ogawa S, Makino S, Sano M & Fukuda K (2006). Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation 114, 2351–2363.
99. Ieda M, Kanazawa H, Kimura K, Hattori F, Ieda Y, Taniguchi M, Lee JK, Matsumura K, Tomita Y, Miyoshi S, Shimoda K, Makino S, Sano M, Kodama I, Ogawa S & Fukuda K (2007). Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 13, 604–612.
100. Jackson KE, Farias M, Stanfill A & Caffrey JL (2001). Delta opioid receptors inhibit vagal bradycardia in the sinoatrial node. J Cardiovasc Pharmacol Ther 6, 385–393.
101. Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B, Yang J, Moore SA, Scholz TD, Strack S, Mohler PJ, Sivitz WI, Song LS & Anderson ME (2012). CaMKII determines mitochondrial stress responses in heart. Nature 491, 269–273.
102. + channel activity. EMBO J 21, 1889–1898.
103. Kakinuma Y, Akiyama T & Sato T (2009). Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium. FEBS J 276, 5111–5125.
104. Kakinuma Y, Tsuda M, Okazaki K, Akiyama T, Arikawa M, Noguchi T & Sato T (2013). Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1α-related defense mechanisms. J Am Heart Assoc 2, e004887.
105. Kalla M, Chotalia M, Coughlan C, Hao G, Crabtree MJ, Tomek J, Bub G, Paterson DJ & Herring N (2016). Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide. J Physiol 594, 3981–3992.
106. Kalmbach A, Hedrick T & Waters J (2012). Selective optogenetic stimulation of cholinergic axons in neocortex. J Neurophysiol 107, 2008–2019.
107. Kanazawa H, Ieda M, Kimura K, Arai T, Kawaguchi-Manabe H, Matsuhashi T, Endo J, Sano M, Kawakami T, Kimura T, Monkawa T, Hayashi M, Iwanami A, Okano H, Okada Y, Ishibashi-Ueda H, Ogawa S & Fukuda K (2010). Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest 120, 408–421.
108. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, Bishe B, Doan BQ, Boerwinkle E, Psaty BM, Tomaselli GF, Coresh J, Siscovick DS, Marban E, Spooner PM, Burke GL & Chakravarti A (2009). Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 119, 940–951.
109. Kawada T, Yamazaki T, Akiyama T, Li M, Zheng C, Shishido T, Mori H & Sugimachi M (2007). Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation. Am J Physiol Heart Circ Physiol 293, H2516–H2522.
110. Kaye DM, Vaddadi G, Gruskin SL, Du XJ & Esler MD (2000). Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 86, E80–E84.
111. Kim RH, Kim DH, Xiao J, Kim BH, Park SI, Panilaitis B, Ghaffari R, Yao J, Li M, Liu Z, Malyarchuk V, Kim DG, Le AP, Nuzzo RG, Kaplan DL, Omenetto FG, Huang Y, Kang Z & Rogers JA (2010). Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater 9, 929–937.
112. Kimura K, Ieda M & Fukuda K (2012). Development, maturation, and transdifferentiation of cardiac sympathetic nerves. Circ Res 110, 325–336.
113. Kimura K, Ieda M, Kanazawa H, Yagi T, Tsunoda M, Ninomiya S, Kurosawa H, Yoshimi K, Mochizuki H, Yamazaki K, Ogawa S & Fukuda K (2007). Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 100, 1755–1764.
114. Kimura K, Kanazawa H, Ieda M, Kawaguchi-Manabe H, Miyake Y, Yagi T, Arai T, Sano M & Fukuda K (2010). Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure. Auton Neurosci 156, 27–35.
115. Komuro I, Kurabayashi M, Takaku F & Yazaki Y (1988). Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62, 1075–1079.
116. Kostreva DR, Zuperku EJ, Cusick JF & Kampine JP (1977). Ventral root mapping of cardiac nerves in the canine using evoked potentials. Am J Physiol 232, H590–H595.
117. Kreipke RE & Birren SJ (2015). Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal. J Physiol 593, 5057–5073.
118. Kristen AV, Kreusser MM, Lehmann L, Kinscherf R, Katus HA, Haass M & Backs J (2006). Preserved norepinephrine reuptake but reduced sympathetic nerve endings in hypertrophic volume-overloaded rat hearts. J Card Fail 12, 577–583.
119. Kuehl M & Stevens MJ (2012). Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol 8, 405–416.
120. 2+/calmodulin-dependent protein kinase. J Biol Chem 260, 6427–6433.
121. 2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am J Physiol Heart Circ Physiol 294, H810–H820.
122. Landis SC & Keefe D (1983). Evidence for neurotransmitter plasticity in vivo: developmental changes in properties of cholinergic sympathetic neurons. Dev Biol 98, 349–372.
123. Lang D, Holzem K, Kang C, Xiao M, Hwang HJ, Ewald GA, Yamada KA & Efimov IR (2015). Arrhythmogenic remodeling of β2 versus β1 adrenergic signaling in the human failing heart. Circ Arrhythm Electrophysiol 8, 409–419.
124. Lefkowitz RJ, Rockman HA & Koch WJ (2000). Catecholamines, cardiac β-adrenergic receptors, and heart failure. Circulation 101, 1634–1637.
125. Leger J, Croll RP & Smith FM (1999). Regional distribution and extrinsic innervation of intrinsic cardiac neurons in the guinea pig. J Comp Neurol 407, 303–317.
126. Lewis ME, Al-Khalidi AH, Bonser RS, Clutton-Brock T, Morton D, Paterson D, Townend JN & Coote JH (2001). Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart. J Physiol 534, 547–552.
127. Li D, Lee CW, Buckler K, Parekh A, Herring N & Paterson DJ (2012). Abnormal intracellular calcium homeostasis in sympathetic neurons from young prehypertensive rats. Hypertension 59, 642–649.
128. Li D, Lu CJ, Hao G, Wright H, Woodward L, Liu K, Vergari E, Surdo NC, Herring N, Zaccolo M & Paterson DJ (2015). Efficacy of B-type natriuretic peptide is coupled to phosphodiesterase 2A in cardiac sympathetic neurons. Hypertension 66, 190–198.
129. Li D, Nikiforova N, Lu CJ, Wannop K, McMenamin M, Lee CW, Buckler KJ & Paterson DJ (2013a). Targeted neuronal nitric oxide synthase transgene delivery into stellate neurons reverses impaired intracellular calcium transients in prehypertensive rats. Hypertension 61, 202–207.
130. Li D, Wang L, Lee CW, Dawson TA & Paterson DJ (2007). Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension 50, 69–74.
131. Li F, Wang X, Capasso JM & Gerdes AM (1996). Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28, 1737–1746.
132. Li J, Levick SP, DiPette DJ, Janicki JS & Supowit SC (2013b). Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure. Regul Pept 185, 20–28.
133. Li M, Zheng C, Sato T, Kawada T, Sugimachi M & Sunagawa K (2004a). Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109, 120–124.
134. Li W, Knowlton D, Van Winkle DM & Habecker BA (2004b). Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am J Physiol Heart Circ Physiol 286, H2229–H2236.
135. Lin JY, Lin MZ, Steinbach P & Tsien RY (2009). Characterization of engineered channelrhodopsin variants with improved properties and kinetics. Biophys J 96, 1803–1814.
136. 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119, 1230–1240.
137. 2+-channel currents in early-stage embryonic mouse heart. Am J Physiol 276, H608–H613.
138. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, Chen LS, Fishbein MC, Chen PS & Lee YT (2003). Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 92, 1145–1152.
139. Lockhart ST, Mead JN, Pisano JM, Slonimsky JD & Birren SJ (2000). Nerve growth factor collaborates with myocyte-derived factors to promote development of presynaptic sites in cultured sympathetic neurons. J Neurobiol 42, 460–476.
140. Lockhart ST, Turrigiano GG & Birren SJ (1997). Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 17, 9573–9582.
141. Longhurst JC, Tjen-A-Looi SC & Fu LW (2001). Cardiac sympathetic afferent activation provoked by myocardial ischemia and reperfusion. Mechanisms and reflexes. Ann NY Acad Sci 940, 74–95.
142. Lorentz CU, Alston EN, Belcik T, Lindner JR, Giraud GD & Habecker BA (2010). Heterogeneous ventricular sympathetic innervation, altered β-adrenergic receptor expression, and rhythm instability in mice lacking the p75 neurotrophin receptor. Am J Physiol Heart Circ Physiol 298, H1652–H1660.
143. Lu CJ, Hao G, Nikiforova N, Larsen HE, Liu K, Crabtree MJ, Li D, Herring N & Paterson DJ (2015). CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension. Hypertension 65, 1288–1297.
144. Lu J, Gao X, Gu J, Zhou L, Guo S, Hao W, Zhou Z & Cao JM (2012). Nerve sprouting contributes to increased severity of ventricular tachyarrhythmias by upregulating iGluRs in rats with healed myocardial necrotic injury. J Mol Neurosci 48, 448–455.
145. Luther JA & Birren SJ (2006). Nerve growth factor decreases potassium currents and alters repetitive firing in rat sympathetic neurons. J Neurophysiol 96, 946–958.
146. Luther JA & Birren SJ (2009). p75 and TrkA signaling regulates sympathetic neuronal firing patterns via differential modulation of voltage-gated currents. J Neurosci 29, 5411–5424.
147. Ma YX, Guo Z & Sun T (2013). CGRP inhibits norepinephrine induced apoptosis with restoration of Bcl-2/Bax in cultured cardiomyocytes of rat. Neurosci Lett 549, 130–134.
148. Mabe AM, Hoard JL, Duffourc MM & Hoover DB (2006). Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene. Cell Tissue Res 326, 57–67.
149. Mabe AM & Hoover DB (2009). Structural and functional cardiac cholinergic deficits in adult neurturin knockout mice. Cardiovasc Res 82, 93–99.
150. Mabe AM & Hoover DB (2011). Remodeling of cardiac cholinergic innervation and control of heart rate in mice with streptozotocin-induced diabetes. Auton Neurosci 162, 24–31.
151. McAllen RM & Spyer KM (1976). The location of cardiac vagal preganglionic motoneurones in the medulla of the cat. J Physiol 258, 187–204.
152. Machhada A, Ang R, Ackland GL, Ninkina N, Buchman VL, Lythgoe MF, Trapp S, Tinker A, Marina N & Gourine AV (2015). Control of ventricular excitability by neurons of the dorsal motor nucleus of the vagus nerve. Heart Rhythm 12, 2285–2293.
153. Mahmoud AI, O'Meara CC, Gemberling M, Zhao L, Bryant DM, Zheng R, Gannon JB, Cai L, Choi WY, Egnaczyk GF, Burns CE, Burns CG, MacRae CA, Poss KD & Lee RT (2015). Nerves regulate cardiomyocyte proliferation and heart regeneration. Dev Cell 34, 387–399.
154. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR & Kass RS (2002). Requirement of a macromolecular signaling complex for β adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295, 496–499.
155. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N & Marks AR (2000). PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365–376.
156. Mastitskaya S, Marina N, Gourine A, Gilbey MP, Spyer KM, Teschemacher AG, Kasparov S, Trapp S, Ackland GL & Gourine AV (2012). Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res 95, 487–494.
157. Melendez GC, Li J, Law BA, Janicki JS, Supowit SC & Levick SP (2011). Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells. Cardiovasc Res 92, 420–429.
158. Meloni M, Caporali A, Graiani G, Lagrasta C, Katare R, Van LS, Spillmann F, Campesi I, Madeddu P, Quaini F & Emanueli C (2010). Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 106, 1275–1284.
159. Meyer T, Hanson PI, Stryer L & Schulman H (1992). Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 256, 1199–1202.
160. Moon JI & Birren SJ (2008). Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway. Dev Biol 315, 404–417.
161. + current and increased ryanodine receptor sensitivity synergistically contribute to sustained focal arrhythmia in the intact rabbit heart. J Physiol 593, 1479–1493.
162. Myles RC, Wang L, Kang C, Bers DM & Ripplinger CM (2012). Local β-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia. Circ Res 110, 1454–1464.
163. Nabauer M, Beuckelmann DJ, Uberfuhr P & Steinbeck G (1996). Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93, 168–177.
164. Nalivaiko E, Antunes VR & Paton JF (2010). Control of cardiac contractility in the rat working heart–brainstem preparation. Exp Physiol 95, 107–119.
165. Nash MP, Thornton JM, Sears CE, Varghese A, O'Neill M & Paterson DJ (2001). Ventricular activation during sympathetic imbalance and its computational reconstruction. J Appl Physiol (1985) 90, 287–298.
166. Ng GA, Brack KE & Coote JH (2001). Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart – a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation. Exp Physiol 86, 319–329.
167. Ng GA, Brack KE, Patel VH & Coote JH (2007). Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res 73, 750–760.
168. Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H, Nagahara D, Shimoshige S, Yuda S, Tsuchihashi K & Shimamoto K (2010). Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med 51, 1241–1249.
169. Norris JE, Foreman RD & Wurster RK (1974). Responses of the canine heart to stimulation of the first five ventral thoracic roots. Am J Physiol 227, 9–12.
170. Nussinovitch U & Gepstein L (2015). Optogenetics for in vivo cardiac pacing and resynchronization therapies. Nat Biotechnol 33, 750–754.
171. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F & Califf RM (2011). Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365, 32–43.
172. O'Shea JE & Evans BK (1985). Innervation of bat heart: cholinergic and adrenergic nerves innervate all chambers. Am J Physiol 249, H876–H882.
173. Olivas A, Gardner RT, Wang L, Ripplinger CM, Woodward WR & Habecker BA (2016). Myocardial infarction causes transient cholinergic transdifferentiation of cardiac sympathetic nerves via gp130. J Neurosci 36, 479–488.
174. Pardini BJ, Lund DD & Schmid PG (1990). Innervation patterns of the middle cervical–stellate ganglion complex in the rat. Neurosci Lett 117, 300–306.
175. Parrish DC, Alston EN, Rohrer H, Nkadi P, Woodward WR, Schutz G & Habecker BA (2009). Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves. Exp Physiol 95, 304–314.
176. Pauza DH, Skripka V, Pauziene N & Stropus R (2000). Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 259, 353–382.
177. Pogwizd SM, Schlotthauer K, Li L, Yuan W & Bers DM (2001). Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 88, 1159–1167.
178. 2+ release refractoriness by β-adrenergic stimulation requires dual activation of kinases PKA and CaMKII in mouse ventricular myocytes. J Physiol 593, 1495–1507.
179. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN & Sadek HA (2011). Transient regenerative potential of the neonatal mouse heart. Science 331, 1078–1080.
180. 2+/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation 128, 1748–1757.
181. Qin F, Vulapalli RS, Stevens SY & Liang CS (2002). Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF. Am J Physiol Heart Circ Physiol 282, H363–H371.
182. Qu J & Robinson RB (2004). Cardiac ion channel expression and regulation: the role of innervation. J Mol Cell Cardiol 37, 439–448.
183. Quan KJ, Lee JH, Geha AS, Biblo LA, Van Hare GF, Mackall JA & Carlson MD (1999). Characterization of sinoatrial parasympathetic innervation in humans. J Cardiovasc Electrophysiol 10, 1060–1065.
184. Quan KJ, Lee JH, Van Hare GF, Biblo LA, Mackall JA & Carlson MD (2002). Identification and characterization of atrioventricular parasympathetic innervation in humans. J Cardiovasc Electrophysiol 13, 735–739.
185. Rana OR, Saygili E, Meyer C, Gemein C, Kruttgen A, Andrzejewski MG, Ludwig A, Schotten U, Schwinger RH, Weber C, Weis J, Mischke K, Rassaf T, Kelm M & Schauerte P (2009). Regulation of nerve growth factor in the heart: The role of the calcineurin-NFAT pathway. J Mol Cell Cardiol 46, 568–578.
186. 2+/calmodulin-dependent kinase II (CaMKII). Circulation 126, 2125–2139.
187. Saito K, Gutkind JS & Saavedra JM (1987). Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol 253, H1618–H1622.
188. Schaeffer C, Vandroux D, Thomassin L, Athias P, Rochette L & Connat JL (2003). Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim Biophys Acta 1643, 65–73.
189. Schmid H, Forman LA, Cao X, Sherman PS & Stevens MJ (1999). Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes 48, 603–608.
190. Schultz HD (2001). Cardiac vagal chemosensory afferents. Ann NY Acad Sci 940, 59–73.
191. 1- but not μ- or κ-opioid receptors. Circulation 97, 1282–1289.
192. Schwartz PJ (2014). Cardiac sympathetic denervation to prevent life-threatening arrhythmias. Nat Rev Cardiol 11, 346–353.
193. Schwarz P, Diem R, Dun NJ & Forstermann U (1995). Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 77, 841–848.
194. 2+(calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem 261, 8581–8584.
195. Shanks J & Herring N (2013). Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides. Am J Physiol Regul Integr Comp Physiol 305, R1411–R1420.
196. Shanks J, Mane S, Ryan R & Paterson DJ (2013a). Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat. Hypertension 61, 187–193.
197. Shanks J, Manou-Stathopoulou S, Lu CJ, Li D, Paterson DJ & Herring N (2013b). Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 305, H980–H986.
198. Shannon TR, Ginsburg KS & Bers DM (2000). Reverse mode of the sarcoplasmic reticulum calcium pump and load-dependent cytosolic calcium decline in voltage-clamped cardiac ventricular myocytes. Biophys J 78, 322–333.
199. Shen MJ & Zipes DP (2014). Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res 114, 1004–1021.
200. Shinlapawittayatorn K, Chinda K, Palee S, Surinkaew S, Kumfu S, Kumphune S, Chattipakorn S, KenKnight BH & Chattipakorn N (2014). Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction. Heart Rhythm 11, 2278–2287.
201. 2+ release events in mouse cardiomyocytes. Biophys J 107, 2815–2827.
202. Singh S, Sayers S, Walter JS, Thomas D, Dieter RS, Nee LM & Wurster RD (2013). Hypertrophy of neurons within cardiac ganglia in human, canine, and rat heart failure: the potential role of nerve growth factor. J Am Heart Assoc 2, e000210.
203. Slonimsky JD, Yang B, Hinterneder JM, Nokes EB & Birren SJ (2003). BDNF and CNTF regulate cholinergic properties of sympathetic neurons through independent mechanisms. Mol Cell Neurosci 23, 648–660.
204. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, Burt RW, Wellman HN & Zipes DP (1989). Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 14, 1519–1526.
205. Steele PA & Choate JK (1994). Innervation of the pacemaker in guinea-pig sinoatrial node. J Auton Nerv Syst 47, 177–187.
206. Sudhof TC & Rothman JE (2009). Membrane fusion: grappling with SNARE and SM proteins. Science 323, 474–477.
207. Sudoh T, Minamino N, Kangawa K & Matsuo H (1990). C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168, 863–870.
208. Swaminathan PD, Purohit A, Hund TJ & Anderson ME (2012). Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 110, 1661–1677.
209. Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ & Anderson ME (2011). Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest 121, 3277–3288.
210. Szentivanyi M, Pace JB, Wechsler JS & Randall WC (1967). Localized myocardial responses to stimulation of cardiac sympathetic nerves. Circ Res 21, 691–702.
211. Takahashi H, Maehara K, Onuki N, Saito T & Maruyama Y (2003). Decreased contractility of the left ventricle is induced by the neurotransmitter acetylcholine, but not by vagal stimulation in rats. Jpn Heart J 44, 257–270.
212. Takata Y, Arai T, Suzuki S, Kurihara J, Uezono T, Okubo Y & Kato H (2004). Captopril enhances cardiac vagal but not sympathetic neurotransmission in pithed rats. J Pharmacol Sci 95, 390–393.
213. Tan EM, Yamaguchi Y, Horwitz GD, Gosgnach S, Lein ES, Goulding M, Albright TD & Callaway EM (2006). Selective and quickly reversible inactivation of mammalian neurons in vivo using the Drosophila allatostatin receptor. Neuron 51, 157–170.
214. Taquet H, Komajda M, Grenier O, Belas F, Landault C, Carayon A, Lechat P, Grosgogeat Y & Legrand JC (1992). Plasma calcitonin gene-related peptide decreases in chronic congestive heart failure. Eur Heart J 13, 1473–1476.
215. Thayer JF & Lane RD (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 74, 224–242.
216. Kr, and the underlying hERG ion channel. Basic Res Cardiol 99, 279–287.
217. Ullman B, Hulting J & Lundberg JM (1994). Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J 15, 454–461.
218. Umoh NA, Walker RK, Millis RM, Al-Rubaiee M, Gangula PR & Haddad GE (2014). Calcitonin gene-related peptide regulates cardiomyocyte survival through regulation of oxidative stress by PI3K/Akt and MAPK signaling pathways. Ann Clin Exp Hypertens 2, 1007.
219. 2+ and phosphorylation. Science 267, 1997–2000.
220. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD & Schwartz PJ (1991). Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68, 1471–1481.
221. Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, Mahajan A & Shivkumar K (2014). Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm 11, 360–366.
222. Vaseghi M, Lux RL, Mahajan A & Shivkumar K (2012). Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am J Physiol Heart Circ Physiol 302, H1838–H1846.
223. Vatner DE, Lavallee M, Amano J, Finizola A, Homcy CJ & Vatner SF (1985). Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog. Circ Res 57, 55–64.
224. i in cardiac sympathetic neurons. J Mol Cell Cardiol 43, 717–725.
225. Wang LH, Zhou SX, Li RC, Zheng LR, Zhu JH, Hu SJ & Sun YL (2012). Serum levels of calcitonin gene-related peptide and substance P are decreased in patients with diabetes mellitus and coronary artery disease. J Int Med Res 40, 134–140.
226. Wang X, Pinol RA, Byrne P & Mendelowitz D (2014). Optogenetic stimulation of locus ceruleus neurons augments inhibitory transmission to parasympathetic cardiac vagal neurons via activation of brainstem α1 and β1 receptors. J Neurosci 34, 6182–6189.
227. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, Edwards WD, Schaff HV & Burnett JC Jr (1993). Natriuretic peptide system in human heart failure. Circulation 88, 1004–1009.
228. Wengrowski AM, Wang X, Tapa S, Posnack NG, Mendelowitz D & Kay MW (2015). Optogenetic release of norepinephrine from cardiac sympathetic neurons alters mechanical and electrical function. Cardiovasc Res 105, 143–150.
229. White IA, Gordon J, Balkan W & Hare JM (2015). Sympathetic reinnervation is required for mammalian cardiac regeneration. Circ Res 117, 990–994.
230. Wu Y, Gao Z, Chen B, Koval OM, Singh MV, Guan X, Hund TJ, Kutschke W, Sarma S, Grumbach IM, Wehrens XH, Mohler PJ, Song LS & Anderson ME (2009). Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc Natl Acad Sci USA 106, 5972–5977.
231. Xenopoulos NP & Applegate RJ (1994). The effect of vagal stimulation on left ventricular systolic and diastolic performance. Am J Physiol 266, H2167–H2173.
232. Xu L, Gutbrod SR, Bonifas AP, Su Y, Sulkin MS, Lu N, Chung HJ, Jang KI, Liu Z, Ying M, Lu C, Webb RC, Kim JS, Laughner JI, Cheng H, Liu Y, Ameen A, Jeong JW, Kim GT, Huang Y, Efimov IR & Rogers JA (2014). 3D multifunctional integumentary membranes for spatiotemporal cardiac measurements and stimulation across the entire epicardium. Nat Commun 5, 3329.
233. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann MJ & Patterson PH (1989). The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246, 1412–1416.
234. Yang Y, Zhu WZ, Joiner ML, Zhang R, Oddis CV, Hou Y, Yang J, Price EE, Gleaves L, Eren M, Ni G, Vaughan DE, Xiao RP & Anderson ME (2006). Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol Heart Circ Physiol 291, H3065–H3075.
235. 2+ channel, GRK2, and phosphorylated phospholamban: protective mechanisms for the denervated failing heart. J Mol Cell Cardiol 40, 619–628.
236. Yoon MS, Han J, Tse WW & Rogers R (1977). Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. Am Heart J 93, 60–65.
237. Younes A, Pepe S, Barron BA, Spurgeon HA, Lakatta EG & Caffrey JL (2000). Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol Heart Circ Physiol 279, H1989–H1998.
238. Zaglia T, Pianca N, Borile G, Da Broi F, Richter C, Campione M, Lehnart SE, Luther S, Corrado D, Miquerol L & Mongillo M (2015). Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2. Proc Natl Acad Sci USA 112, E4495–4504.
239. Zak R (1973). Cell proliferation during cardiac growth. Am J Cardiol 31, 211–219.
240. Zarzoso M, Rysevaite K, Milstein ML, Calvo CJ, Kean AC, Atienza F, Pauza DH, Jalife J & Noujaim SF (2013). Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function. Cardiovasc Res 99, 566–575.
241. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G, Price EE, Thiel W, Guatimosim S, Song LS, Madu EC, Shah AN, Vishnivetskaya TA, Atkinson JB, Gurevich VV, Salama G, Lederer WJ, Colbran RJ & Anderson ME (2005). Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11, 409–417.
242. Zhang X, Szeto C, Gao E, Tang M, Jin J, Fu Q, Makarewich C, Ai X, Li Y, Tang A, Wang J, Gao H, Wang F, Ge XJ, Kunapuli SP, Zhou L, Zeng C, Xiang KY & Chen X (2013). Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ Res 112, 498–509.
243. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, Fishbein MC, Sharifi B & Chen PS (2004). Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95, 76–83.